New Diabetes Caused by Immunotherapy — Why It Can Start Almost Overnight
Immunotherapy can, in rare cases, permanently switch off the pancreas's insulin-producing cells within days rather than years — a pattern that looks nothing like the gradual high blood sugar many patients expect on steroids. ASCO and NCCN guidance on immune-related endocrine effects lists this among the irAEs needing same-day recognition, because some patients are first diagnosed only after reaching diabetic ketoacidosis, a medical emergency.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Know the emergency signs — extreme thirst, vomiting and drowsiness together need care today, not a wait-and-see approach.
- Understand why it's sudden — this is not routine steroid-related high sugar; it can appear within days, sometimes after a single dose.
- It's usually lifelong — once confirmed, insulin therapy is typically needed for life, directed by your care team.
- Your cancer treatment usually continues — in most cases immunotherapy carries on once your sugar levels are stabilised.
on Panel
Survival Rate*
Treated
(800+ reviews)
If You Have Extreme Thirst, Vomiting and Drowsiness Together, Call Now
Extreme thirst, urinating far more than usual, vomiting, deep or unusually fast breathing, severe abdominal pain, or drowsiness and confusion appearing together — especially early in immunotherapy — can mean diabetic ketoacidosis, a medical emergency caused by suddenly very high blood sugar with too little insulin. This is not a symptom to monitor overnight. Go to the nearest emergency room now, or call for help immediately, and say clearly that you're on immunotherapy for cancer.
Go to the ER now if you notice any of these:
- Extreme thirst and urinating far more than usual
- Vomiting, or deep, unusually fast breathing
- Severe abdominal pain
- Drowsiness, confusion or difficulty staying awake
Other hormone-related immunotherapy emergencies, such as adrenal crisis, need this same urgent response — never a wait-and-see approach. If none of this is happening right now, here is the honest picture of how immunotherapy causes new diabetes, why it can appear so suddenly, and whether it goes away.
How Does Immunotherapy Cause New Diabetes?
Immunotherapy occasionally triggers the immune system to attack the insulin-producing beta cells inside the pancreas — the same cells destroyed in classic type 1 diabetes. Once enough cells are destroyed, the pancreas can no longer make its own insulin, and blood sugar rises quickly regardless of diet, weight or family history.
This is different from every other cause of high blood sugar you may already know. It isn't related to being overweight, family history, or long-term steroid use, and it isn't the everyday type 2 diabetes seen with age. Checkpoint-inhibitor immunotherapy — used across many solid tumours and blood cancers — is the class most associated with this reaction, though it remains uncommon overall: it's reported in well under 1 in 100 patients on PD-1/PD-L1 inhibitors, per ASCO's irAE management guidance. Because the drop in insulin can be near-complete rather than partial, its effect is often more dramatic than its rarity suggests.
Why Does It Come On So Suddenly, Unlike Type 2 Diabetes?
Type 2 diabetes develops gradually over years as the body's insulin response slowly weakens. Immunotherapy-induced diabetes is different — the immune attack on insulin-producing cells can be fast and complete, so blood sugar can rise from normal to dangerously high within days, sometimes after a single dose.
| Feature | Type 2 diabetes | Steroid-related high sugar | Immunotherapy-induced diabetes |
|---|---|---|---|
| Onset speed | Over years | Days to weeks, while on steroids | Can be days, sometimes after a single dose |
| Underlying cause | Gradual insulin resistance | Effect of steroid medication | Immune destruction of insulin-producing cells |
| Usually reversible? | Managed long-term, rarely reversed | Often improves once steroid dose is reduced | Not usually reversible once confirmed |
| Ketoacidosis risk | Low, unless very advanced | Low | Notable — some patients present in ketoacidosis at diagnosis |
| First-line treatment | Tablets, lifestyle, sometimes insulin | Adjust steroid dose, monitor sugar | Insulin, usually from diagnosis onward |
If you're on steroids as part of your cancer or irAE treatment and your sugar is high, that's usually the steroid, not this. Your care team tells the two apart with blood and urine ketone tests, not guesswork.
Is Immunotherapy-Induced Diabetes Permanent?
In almost all reported cases, once immunotherapy has destroyed enough insulin-producing cells to cause diabetes, that damage does not reverse. Lifelong insulin is usually needed, in the same way it is for classic type 1 diabetes — a diagnosis for life, not a side effect that fades once immunotherapy ends.
That is a significant adjustment, and it deserves a straightforward answer rather than false reassurance. It is also a very manageable one: insulin-dependent diabetes is one of the most extensively studied chronic conditions in medicine, and your endocrinology-linked oncology team sets up monitoring and dosing exactly as they would for anyone newly diagnosed with type 1 diabetes — never something to start, adjust or stop on your own.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get Clarity on Your Blood Sugar Results
Our tumour board includes the same endocrinology-linked oncology team managing your immunotherapy — reach them directly.
How Soon After Starting Immunotherapy Does New Diabetes Appear?
New diabetes from immunotherapy has no fixed timeline. It can appear within the first few weeks, well into a treatment course, or occasionally even after immunotherapy has stopped — which is why the warning signs matter for as long as you're on treatment and for some time after.
| Pattern | Typically starts | Notes |
|---|---|---|
| Earliest reported onset | After a single dose | Rare, but the reason sudden thirst or fatigue is never dismissed as "just tiredness" |
| Median reported onset | Around cycle 4–6 (roughly 2–4 months) | Most published cases fall in this window |
| Later onset | Any time during treatment | Some patients develop it after many months of otherwise uneventful therapy |
| After stopping treatment | Uncommon, but reported | A reason to keep knowing the warning signs even after your last dose |
Because the timing varies this much, routine blood sugar checks — not just symptom-watching — are part of monitoring through your immunotherapy course.
What Happens Once New Diabetes Is Diagnosed?
Diagnosis and the first few days of treatment happen quickly, because untreated high blood sugar from this cause can escalate. Here's the sequence most patients go through.
- 1
Confirm with blood and ketone tests
Blood glucose, blood or urine ketones, and sometimes antibody or C-peptide testing confirm the diagnosis and rule out a simple steroid-related sugar rise.
- 2
Stabilise first, if needed
If ketoacidosis is present, this is treated in hospital with fluids and insulin before anything else is decided.
- 3
Start insulin therapy
Once stable, insulin is started as the primary treatment — tablets used for type 2 diabetes are not the right tool here.
- 4
Endocrinology takes the lead
Your endocrinology-linked oncology team manages dosing, targets and adjustments going forward, working alongside your oncologist.
- 5
Immunotherapy is usually continued
Unlike some other immune reactions, new diabetes typically does not require pausing immunotherapy once your sugar is controlled — a decision your tumour board confirms case by case.
What Does Ongoing Insulin Therapy Cost?
Lifelong insulin therapy has ongoing costs beyond the medicine itself — monitoring supplies and regular check-ups matter as much as the insulin dose. The figures below are indicative, as of August 2026, and vary by brand, dose, delivery device and pharmacy — they are not a quote for your treatment.
| Item | Indicative monthly cost (Aug 2026) | Notes |
|---|---|---|
| Insulin (injectable) | Indicative ₹500–2,500 | Varies widely by insulin type and daily dose required |
| Blood glucose monitoring strips / glucometer | Indicative ₹300–1,000 | Testing frequency is higher in the first few months |
| Periodic HbA1c and kidney function tests | Indicative ₹600–1,500 per cycle | Usually every 3 months once stable |
| Endocrinology follow-up visit | Indicative ₹500–1,500 per visit | Frequency reduces once your dose is stable |
Aarogyasri and other government scheme coverage for ongoing diabetes management varies by scheme category, centre and current empanelment — ask our team directly what applies to your situation rather than relying on a fixed figure here.
Living With Insulin-Dependent Diabetes During Cancer Treatment
Adjusting to insulin-dependent diabetes while also managing a cancer diagnosis is genuinely a lot at once — and it's fair to feel that. Most patients do settle into a working routine within a few weeks, once dosing is stable and the initial adjustment period passes.
- 1
Learn to check and log blood sugar
A simple daily log helps your team fine-tune your dose faster than symptoms alone.
- 2
Understand "sick-day rules"
Illness, infection or a missed meal can change your insulin needs; your team gives you clear rules to follow.
- 3
Carry identification
A card or phone note stating you are insulin-dependent and on immunotherapy helps any emergency team treat you correctly.
- 4
Loop in family or a caregiver
Someone close to you should know the warning signs of both very high and very low blood sugar.
- 5
Keep every follow-up
Even once you feel well, regular review catches dose changes before symptoms would.
Here is the honest picture: for some patients, immunotherapy replaces one long-term condition with another. It is also one of the best-understood chronic conditions in medicine, and your care team stays involved for as long as you need them — through your cancer treatment and beyond it.
Insulin-Dependent Diabetes Is Manageable, Not Limiting
Patients newly started on insulin are supported with the same structured monitoring throughout survivorship.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.New Diabetes From Immunotherapy: Your Questions Answered
How does immunotherapy cause new diabetes?
Immunotherapy can occasionally trigger the immune system to attack the insulin-producing beta cells inside the pancreas — the same cells destroyed in classic type 1 diabetes. Once enough of these cells are destroyed, the pancreas can no longer make its own insulin, and blood sugar rises quickly regardless of your diet, weight or family history. This is most associated with checkpoint-inhibitor immunotherapy and remains uncommon overall, affecting well under 1 in 100 patients on these medicines, per ASCO's irAE management guidance, though because the insulin drop can be near-complete rather than partial, its effect is often dramatic when it happens.
Why does this diabetes come on so suddenly, unlike type 2 diabetes?
Type 2 diabetes develops gradually over years as the body's insulin response slowly weakens. Immunotherapy-induced diabetes works differently — the immune attack on insulin-producing cells can be fast and complete, so blood sugar can rise from normal to dangerously high within days, sometimes after a single dose. It also isn't the same as the milder, more gradual high blood sugar some patients see while on steroids for cancer or irAE treatment, which usually improves once the steroid dose is reduced. Your care team tells these apart with blood and urine ketone tests, not by how you feel alone.
Is immunotherapy-induced diabetes permanent?
In almost all reported cases, yes. Once immunotherapy has destroyed enough insulin-producing cells to cause diabetes, that damage does not reverse, and lifelong insulin is usually needed — in the same way it is for classic type 1 diabetes. This is a genuine, lasting adjustment rather than a side effect that fades once immunotherapy ends. It is also a very manageable one: insulin-dependent diabetes is one of the most extensively studied chronic conditions in medicine, and your endocrinology-linked oncology team sets up monitoring and dosing for you, exactly as they would for anyone newly diagnosed with type 1 diabetes.
What are the warning signs of diabetic ketoacidosis I should never ignore?
Extreme thirst, urinating far more than usual, vomiting, deep or unusually fast breathing, severe abdominal pain, and drowsiness or confusion appearing together can mean diabetic ketoacidosis — a medical emergency caused by very high blood sugar with too little insulin. This is not something to monitor overnight or manage at home. Go to the nearest emergency room immediately, or call for help right away, and clearly tell the team you are on immunotherapy for cancer. Other hormone-related immunotherapy emergencies, such as adrenal crisis, need this same urgent response rather than a wait-and-see approach.
Will I need to stop immunotherapy if I develop diabetes from it?
Usually not. Unlike some other immune-related reactions, new diabetes typically does not require pausing immunotherapy once your blood sugar is stabilised and insulin therapy has started. Your tumour board reviews this case by case alongside your oncologist and endocrinology-linked team, weighing your specific cancer treatment plan against how well your sugar levels are controlled. Most patients continue their planned immunotherapy course while managing diabetes as a separate, parallel condition — one more reason early recognition and stabilisation matter, rather than delaying treatment decisions out of fear of this reaction.
What does ongoing insulin therapy cost, and can government schemes help?
Ongoing costs include insulin itself, blood glucose monitoring supplies, and periodic blood tests, and these vary by insulin type, dose, device and pharmacy. As an indicative guide only, as of August 2026, monthly costs commonly range from roughly ₹500–2,500 for insulin plus ₹300–1,000 for monitoring supplies, with quarterly blood tests costing separately. Aarogyasri and other government scheme coverage for ongoing diabetes management varies by scheme category, centre and current empanelment — our team can confirm exactly what applies to your situation rather than relying on a general figure.